Traws Pharma, Inc. (TRAW) — Institutional Holders, Q2 2026

34 institutional investment managers reported a TRAW position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $5.2M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

TRAW in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

13

Added to

9

Trimmed

8

Sold out

7

Biggest buyers

  1. Ally Bridge Group (NY)New · +786,236 sh+$663.0K
  2. ORBIMED ADVISORSAdded · +597,729 sh+$504.1K
  3. Lynx1 Capital ManagementAdded · +544,392 sh+$459.1K
  4. ADAR1 Capital ManagementAdded · +443,631 sh+$374.1K
  5. SPHERA FUNDS MANAGEMENT LTD.New · +398,486 sh+$336.0K

Biggest sellers

  1. Squadron Capital ManagementSold out · -511,714 sh-$431.5K
  2. Dauntless Investment GroupTrimmed · -336,424 sh-$283.7K
  3. Ikarian CapitalTrimmed · -200,000 sh-$168.7K
  4. Palumbo Wealth ManagementSold out · -61,175 sh-$51.6K
  5. BOOTHBAY FUND MANAGEMENTTrimmed · -60,600 sh-$51.1K

TRAW 13F holders ranked 1–34 of 34

Institutional investors reporting a position in Traws Pharma, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
ORBIMED ADVISORS#1 · 1,203,260 sh$1.0M+98.7%
Ally Bridge Group (NY)#2 · 786,236 sh$663.0KNew
ADAGE CAPITAL PARTNERS GP, L.L.C.#3 · 730,000 sh$615.6K0.0%
ADAR1 Capital Management#4 · 597,729 sh$504.1K+287.9%
Lynx1 Capital Management#5 · 559,470 sh$471.8K+3610.5%
Ikarian Capital#6 · 478,142 sh$403.2K-29.5%
SPHERA FUNDS MANAGEMENT LTD.#7 · 398,486 sh$336.0KNew
VANGUARD CAPITAL MANAGEMENT#8 · 330,049 sh$278.2K+498.0%
JANE STREET GROUP#9 · 216,006 sh$182.2K+916.9%
Alyeska Investment Group, L.P.#10 · 164,376 sh$138.6KNew
BOOTHBAY FUND MANAGEMENT#11 · 133,936 sh$112.9K-31.2%
GEODE CAPITAL MANAGEMENT#12 · 111,365 sh$93.9K+44.4%
HRT FINANCIAL#13 · 91,220 sh$76.0KNew
Kynam Capital Management#14 · 84,400 sh$71.2KNew
Dauntless Investment Group#15 · 80,574 sh$67.9K-80.7%
VANGUARD FIDUCIARY#16 · 54,511 sh$46.0K+71.4%
NORTHERN#17 · 37,454 sh$31.6KNew
STATE STREET#18 · 25,802 sh$21.8K0.0%
XTX Topco Ltd#19 · 18,092 sh$15.3KNew
SG Americas Securities#20 · 14,524 sh$12.0KNew
Virtu Financial#21 · 12,579 sh$11.0KNew
BlackRock#22 · 9,941 sh$8.4K-0.2%
Tower Research Capital (TRC)#23 · 5,142 sh$4.3K+29.7%
HUNTINGTON NATIONAL BANK#24 · 4,676 sh$3.9KNew
UBS Group AG#25 · 3,451 sh$2.9K-14.9%
BARCLAYS PLC#26 · 1,947 sh$1.6KNew
SBI Securities , Ltd.#27 · 1,721 sh$1.5K+1244.5%
Federation des caisses Desjardins du Quebec#28 · 500 sh$414.00New
MORGAN STANLEY#29 · 468 sh$395.00-87.4%
Vanguard Global Advisers#30 · 262 sh$221.000.0%
Cassaday & Wealth Management#31 · 6 sh$6.00-45.5%
Integrated Wealth Concepts#32 · 2 sh$2.00New
FMR#33 · 2 sh$2.00-91.3%
JONES FINANCIAL COMPANIES LLLP#34 · 2 sh$2.000.0%

Funds that sold out of TRAW in Q2 2026 (7)

Held TRAW at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held TRAW in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
Squadron Capital Management511,714 sh$936.4K
Palumbo Wealth Management61,175 sh$112.0K
TWO SIGMA INVESTMENTS19,244 sh$35.2K
Robinswood Financial5 sh$9.00
NORTHWESTERN MUTUAL WEALTH MANAGEMENT2 sh$4.00
Caitong International Asset Management , Ltd2 sh$4.00
ROYAL BANK OF CANADA6 sh$0.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.